Identification of novel markers that outperform EpCAM in quantifying circulating tumor cells

Cellular Oncology

Volumn 37, Issue 4, 2014, Pages 235-243

  Kim, Min Ji ^a   Choi, Na Young ^b   Lee, Eun Kyung ^a,c   Kang, Myung Soo ^a,c,d  

^a Samsung Medical Center   (South Korea)

^b Kyungdong University   (South Korea)

^c Sungkyunkwan University   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

CCLE database; CD45; Circulating tumor cells; CTC; EpCAM; Novel markers; PTPRC

Indexed keywords

BIOLOGICAL MARKER; EPITHELIAL CELL ADHESION MOLECULE; ANTIBODY; CELL ADHESION MOLECULE; EPCAM PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR MARKER;

ARTICLE; BIOINFORMATICS; CANCER CELL LINE; CIRCULATING TUMOR CELL; DATA BASE; GENE EXPRESSION PROFILING; MICROARRAY ANALYSIS; PRIORITY JOURNAL; BIOLOGY; GENETIC DATABASE; HUMAN; IMMUNOLOGY; METABOLISM; PROCEDURES; TUMOR CELL LINE; TUMOR EMBOLISM;

ANTIBODIES; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; HUMANS; NEOPLASTIC CELLS, CIRCULATING; TUMOR MARKERS, BIOLOGICAL;

EID: 84906936120     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-014-0178-4     Document Type: Article

References (23)

1. S. Maheswaran, D.A. Haber, Circulating tumor cells: a window into cancer biology and metastasis. Curr. Opin. Genet. Dev. 20, 96-99 (2010)
2. R.T. Krivacic, A. Ladanyi, D.N. Curry, H.B. Hsieh, P. Kuhn, D.E. Bergsrud, J.F. Kepros, T. Barbera, M.Y. Ho, L.B. Chen, R.A. Lerner, R.H. Bruce, A rare-cell detector for cancer. Proc. Natl. Acad. Sci. U. S. A. 101, 10501-10504 (2004)
3. K. Pantel, R.H. Brakenhoff, B. Brandt, Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat. Rev. Cancer 8, 329-340 (2008)
4. S. Riethdorf, K. Pantel, Advancing personalized cancer therapy by detection and characterization of circulating carcinoma cells. Ann. N. Y. Acad. Sci. 1210, 66-77 (2010)
5. L.H. Broersen, G.W. van Pelt, R.A. Tollenaar, W.E. Mesker, Clinical application of circulating tumor cells in breast cancer. Cell. Oncol. 37, 9-15 (2014)
6. Y. Liu, J. Qian, J.G. Feng, H.X. Ju, Y.P. Zhu, H.Y. Feng, D.C. Li, Detection of circulating tumor cells in peripheral blood of colorectal cancer patients without distant organ metastases. Cell. Oncol. 36, 43-53 (2013)
7. E. Racila, D. Euhus, A.J. Weiss, C. Rao, J. McConnell, L.W. Terstappen, J.W. Uhr, Detection and characterization of carcinoma cells in the blood. Proc. Natl. Acad. Sci. U. S. A. 95, 4589-4594 (1998)
8. M.S. Wicha, D.F. Hayes, Circulating tumor cells: not all detected cells are bad and not all bad cells are detected. J. Clin. Oncol. 29, 1508-1511 (2011)
9. M. Cristofanilli, G.T. Budd, M.J. Ellis, A. Stopeck, J. Matera, M.C. Miller, J.M. Reuben, G.V. Doyle, W.J. Allard, L.W. Terstappen, D.F. Hayes, Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N. Engl. J. Med. 351, 781-791 (2004)
10. J.S. de Bono, H.I. Scher, R.B. Montgomery, C. Parker, M.C. Miller, H. Tissing, G.V. Doyle, L.W. Terstappen, K.J. Pienta, D. Raghavan, Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin. Cancer Res. 14, 6302-6309 (2008)
11. S.A. Mani, W. Guo, M.J. Liao, E.N. Eaton, A. Ayyanan, A.Y. Zhou, M. Brooks, F. Reinhard, C.C. Zhang, M. Shipitsin, L.L. Campbell, K. Polyak, C. Brisken, J. Yang, R.A. Weinberg, The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133, 704-715 (2008)
12. K. Polyak, R.A. Weinberg, Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat. Rev. Cancer 9, 265-273 (2009)
13. A. Gradilone, C. Raimondi, C. Nicolazzo, A. Petracca, O. Gandini, B. Vincenzi, G. Naso, A.M. Agliano, E. Cortesi, P. Gazzaniga, Circulating tumour cells lacking cytokeratin in breast cancer: the importance of being mesenchymal. J. Cell. Mol. Med. 15, 1066-1070 (2011)
14. H.I. Scher, X. Jia, K. Chi, R. de Wit, W.R. Berry, P. Albers, B. Henick, D. Waterhouse, D.J. Ruether, P.J. Rosen, A.A. Meluch, L.T. Nordquist, P.M. Venner, A. Heidenreich, L. Chu, G. Heller, Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer. J. Clin. Oncol. 29, 2191-2198 (2011)
15. S. Riethdorf, H. Fritsche, V.Muller, T. Rau, C. Schindlbeck, B. Rack, W. Janni, C. Coith, K. Beck, F. Janicke, S. Jackson, T. Gornet, M. Cristofanilli, K. Pantel, Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the Cell Search system. Clin. Cancer Res. 13, 920-928 (2007)
16. T. Blick, H. Hugo, E. Widodo, M. Waltham, C. Pinto, S.A. Mani, R.A. Weinberg, R.M. Neve, M.E. Lenburg, E.W. Thompson, Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stemcell phenotype in human breast cancer. J. Mammary Gland Biol. Neoplasia 15, 235-252 (2010)
17. J. Barretina, G. Caponigro, N. Stransky, K. Venkatesan, A. A. Margolin, S. Kim, C.J. Wilson, J. Lehar, G.V. Kryukov, D. Sonkin, A. Reddy, M. Liu, L. Murray, M.F. Berger, J.E. Monahan, P. Morais, J. Meltzer, A. Korejwa, J. Jane-Valbuena, F.A. Mapa, J. Thibault, E. Bric-Furlong, P. Raman, A. Shipway, I.H. Engels, J. Cheng, G.K. Yu, J. Yu, P. Aspesi Jr., M. de Silva, K. Jagtap, M.D. Jones, L.Wang, C. Hatton, E. Palescandolo, S. Gupta, S. Mahan, C. Sougnez, R.C. Onofrio, T. Liefeld, L. MacConaill, W. Winckler, M. Reich, N. Li, J.P. Mesirov, S.B. Gabriel, G. Getz, K. Ardlie, V. Chan, V.E. Myer, B.L. Weber, J. Porter, M. Warmuth, P. Finan, J.L. Harris, M. Meyerson, T.R. Golub, M.P. Morrissey, W.R. Sellers, R. Schlegel, L.A. Garraway, The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603-607 (2012)
18. W. da Huang, B.T. Sherman, R.A. Lempicki, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57 (2009)
19. W. da Huang, B.T. Sherman, R.A. Lempicki, Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1-13 (2009)
20. A. Gradilone, E. Cigna, A.M. Agliano, L. Frati, Tyrosinase expression as a molecular marker for investigating the presence of circulating tumor cells in melanoma patients. Curr. Cancer Drug Targets 10, 529-538 (2010)
21. B.J. Kirby, M. Jodari, M.S. Loftus, G. Gakhar, E.D. Pratt, C. Chanel-Vos, J.P. Gleghorn, S.M. Santana, H. Liu, J.P. Smith, V.N. Navarro, S.T. Tagawa, N.H. Bander, D.M. Nanus, P. Giannakakou, Functional characterization of circulating tumor cells with a prostate-cancerspecific microfluidic device. PLoS One 7, e35976 (2012)
22. T. Yokobori, H. Iinuma, T. Shimamura, S. Imoto, K. Sugimachi, H. Ishii, M. Iwatsuki, D. Ota, M. Ohkuma, T. Iwaya, N. Nishida, R. Kogo, T. Sudo, F. Tanaka, K. Shibata, H. Toh, T. Sato, G.F. Barnard, T. Fukagawa, S. Yamamoto, H. Nakanishi, S. Sasaki, S. Miyano, T. Watanabe, H. Kuwano, K. Mimori, K. Pantel, M. Mori, Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis. Cancer Res. 73, 2059-2069 (2013)
23. V. Zieglschmid, C. Hollmann, O. Bocher, Detection of disseminated tumor cells in peripheral blood. Crit. Rev. Clin. Lab. Sci. 42, 155-196 (2005)